Sphingosine 1-phosphate receptor agonists attenuate relapsing–remitting experimental autoimmune encephalitis in SJL mice
暂无分享,去创建一个
J. Chun | T. Rao | C. Tham | M. Webb | N. Yu | S. Mandala | F. Lin | Karen D. Lariosa-Willingham | J. Hale
[1] R. Proia,et al. Immune Cell Regulation and Cardiovascular Effects of Sphingosine 1-Phosphate Receptor Agonists in Rodents Are Mediated via Distinct Receptor Subtypes , 2004, Journal of Pharmacology and Experimental Therapeutics.
[2] N. Gray,et al. Sphingosine 1-Phosphate (S1P) Receptor Subtypes S1P1 and S1P3, Respectively, Regulate Lymphocyte Recirculation and Heart Rate* , 2004, Journal of Biological Chemistry.
[3] R. Proia,et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1 , 2004, Nature.
[4] E. Goetzl,et al. The immunosuppressant FTY720 down‐regulates sphingosine 1‐phosphate G protein‐coupled receptors , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[5] K. Claffey,et al. Phosphorylation and Action of the Immunomodulator FTY720 Inhibits Vascular Endothelial Cell Growth Factor-induced Vascular Permeability* , 2003, Journal of Biological Chemistry.
[6] M. Forrest,et al. Sphingosine-1-Phosphate Receptor Agonism Impairs the Efficiency of the Local Immune Response by Altering Trafficking of Naive and Antigen-Activated CD4+ T Cells , 2003, The Journal of Immunology.
[7] H. Amemiya,et al. Amelioration of Experimental Autoimmune Encephalomyelitis in Lewis Rats by FTY720 Treatment , 2003, Journal of Pharmacology and Experimental Therapeutics.
[8] V. Ling,et al. Local delivery of granulocyte macrophage colony-stimulating factor by retrovirally transduced antigen-specific T cells leads to severe, chronic experimental autoimmune encephalomyelitis in mice , 2002, Neuroscience Letters.
[9] J. Dwyer,et al. Estrogen inhibition of EAE involves effects on dendritic cell function , 2002, Journal of neuroscience research.
[10] D. Bourdette,et al. Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis , 2002, Journal of Neuroimmunology.
[11] Michael D. Davis,et al. The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors* , 2002, The Journal of Biological Chemistry.
[12] H. Rosen,et al. Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists , 2002, Science.
[13] B. Trapp,et al. Axon Loss in the Spinal Cord Determines Permanent Neurological Disability in an Animal Model of Multiple Sclerosis , 2002, Journal of neuropathology and experimental neurology.
[14] J. McQualter,et al. Granulocyte Macrophage Colony-Stimulating Factor A New Putative Therapeutic Target in Multiple Sclerosis , 2001 .
[15] V. Brinkmann,et al. FTY720: altered lymphocyte traffic results in allograft protection. , 2001, Transplantation.
[16] V. Brinkmann,et al. FTY720 alters lymphocyte homing and protects allografts without inducing general immunosuppression. , 2001, Transplantation proceedings.
[17] T. Imayoshi,et al. Effect of FTY720, a novel immunosuppressant, on adjuvant-induced arthritis in rats , 2000, Inflammation Research.
[18] S. Enosawa,et al. Evidence that FTY720 induces T cell apoptosis in vivo. , 2000, Immunopharmacology.
[19] R. Zinkernagel,et al. FTY720 Immunosuppression Impairs Effector T Cell Peripheral Homing Without Affecting Induction, Expansion, and Memory1 , 2000, The Journal of Immunology.
[20] L. Feng,et al. FTY720: a novel transplantation drug that modulates lymphocyte traffic rather than activation. , 2000, Trends in pharmacological sciences.
[21] J. Bronstein,et al. Oligodendrocyte-specific protein peptides induce experimental autoimmune encephalomyelitis in SJL/J mice. , 1999, Journal of immunology.
[22] B D Trapp,et al. Axonal pathology in multiple sclerosis: relationship to neurologic disability. , 1999, Current opinion in neurology.
[23] E. Goetzl,et al. Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1‐phosphate , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[24] S. Suzuki,et al. Prevention of experimentally induced autoimmune type I diabetes in rats by the new immunosuppressive reagent FTY720. , 1998, Transplantation proceedings.
[25] K. Sugahara,et al. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo. , 1998, Journal of immunology.
[26] H. Kataoka,et al. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. , 1998, Journal of immunology.
[27] S. Enosawa,et al. The in vivo induction of lymphocyte apoptosis in MRL‐lpr/lpr mice treated with FTY720 , 1997, Clinical and experimental immunology.
[28] S. Enosawa,et al. A new immunosuppressant, FTY720, induces bcl‐2‐associated apoptotic cell death in human lymphocytes , 1996, Immunology.
[29] Y. Yanagawa,et al. FTY720, a novel immunosuppressant possessing unique mechanisms. I. Prolongation of skin allograft survival and synergistic effect in combination with cyclosporine in rats. , 1996, Transplantation proceedings.
[30] K. Chiba,et al. FTY720, a novel immunosuppressant, possessing unique mechanisms. IV. Prevention of graft versus host reactions in rats. , 1996, Transplantation proceedings.
[31] S. Enosawa,et al. A novel immunosuppressant, FTY720, with a unique mechanism of action, induces long-term graft acceptance in rat and dog allotransplantation. , 1996, Transplantation.
[32] S. Miller,et al. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis , 1995, The Journal of experimental medicine.
[33] S. Miller,et al. Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein , 1992, Journal of Neuroimmunology.
[34] R. Sobel,et al. Acute Experimental Allergic Encephalomyelitis in SJL/J Mice Induced by a Synthetic Peptide of Myelin Proteolipid Protein , 1990, Journal of neuropathology and experimental neurology.
[35] W. Sewell,et al. Inhibition of lymphocyte circulation in mice by pertussis toxin , 1989, Immunology and cell biology.
[36] A. Cooke,et al. Immunological defects in SJL mice. , 1986, Immunology.
[37] D. McFarlin,et al. Chronologic neuropathology of relapsing experimental allergic encephalomyelitis in the mouse. , 1982, Laboratory investigation; a journal of technical methods and pathology.
[38] J. Weiner,et al. Lysophospholipid receptors. , 2001, Annual review of pharmacology and toxicology.
[39] J. Chun. Lysophospholipid receptors: implications for neural signaling. , 1999, Critical reviews in neurobiology.
[40] ichard,et al. AXONAL TRANSECTION IN THE LESIONS OF MULTIPLE SCLEROSIS , 1998 .
[41] Journal of Neuroimmunology , 2022 .